Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jeffrey Rona, Mark Colonnese

Premium

Transgenomic said this week that Mark Colonnese has resigned as CFO and executive VP effective October 30, 2014. Transgenomics President and CEO Paul Kinnon will assume the role of interim CFO.

Additionally, Leon Richards, Transgenomic's corporate controller, will take on additional responsibilities as chief accounting officer. Richards joined the financial group at Transgenomic in 2012. Previously, he served as corporate controller and chief accounting officer at Baldwin Technology Company. Earlier in his career he was director of financial reporting and control at Ciba Specialty Chemicals (now BASF), and he also held positions of increasing responsibility in the financial group at Hercules (now Ashland Chemical).


Molecular diagnostics firm Great Basin Scientific has appointed Jeffrey Rona as CFO. His appointment went into effect on Oct. 8 in conjunction with the company's initial public offering.

Rona has served as a financial consultant to Great Basin since 2012 in his role as the managing director of Rona Capital, a life sciences-focused transactional advisory consultancy founded in 2011. From 2006 to 2011, Rona was the chief business officer of GlobeImmune. Prior to that, he was VP of corporate development for Corgentech, following the merger between Corgentech and AlgoRx Pharmaceuticals in 2005. At AlgoRx, he was CFO and responsible for the execution of the merger with Corgentech. Rona has also worked for UBS Warburg, Antigenics (now Agenus), and Coopers and Lybrand.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.